0001878646-22-000061.txt : 20221230 0001878646-22-000061.hdr.sgml : 20221230 20221230155345 ACCESSION NUMBER: 0001878646-22-000061 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221230 DATE AS OF CHANGE: 20221230 EFFECTIVENESS DATE: 20221230 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Palvella Therapeutics, Inc. CENTRAL INDEX KEY: 0001742961 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 812228053 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-469329 FILM NUMBER: 221501946 BUSINESS ADDRESS: STREET 1: 125 STRAFFORD AVENUE STREET 2: STE 360 CITY: WAYNE STATE: PA ZIP: 19087 BUSINESS PHONE: 800-484-0260 MAIL ADDRESS: STREET 1: 125 STRAFFORD AVENUE STREET 2: STE 360 CITY: WAYNE STATE: PA ZIP: 19087 D 1 primary_doc.xml X0708 D LIVE 0001742961 Palvella Therapeutics, Inc. 125 STRAFFORD AVENUE STE 360 WAYNE PA PENNSYLVANIA 19087 484-253-1461 DELAWARE None None Corporation true Wesley H. Kaupinen 125 Strafford Avenue Suite 360 Wayne PA PENNSYLVANIA 19087 Executive Officer Director Scott Morenstein 125 Strafford Avenue Suite 360 Wayne PA PENNSYLVANIA 19087 Director George Jenkins 125 Strafford Avenue Suite 360 Wayne PA PENNSYLVANIA 19087 Director Aditya Asokan 125 Strafford Avenue Suite 360 Wayne PA PENNSYLVANIA 19087 Director Todd Davis 125 Strafford Avenue Suite 360 Wayne PA PENNSYLVANIA 19087 Director Tadd S Wessel 125 Strafford Avenue Suite 360 Wayne PA PENNSYLVANIA 19087 Director Kathleen McGowan 125 Strafford Avenue Suite 360 Wayne PA PENNSYLVANIA 19087 Executive Officer Kathleen Goin 125 Strafford Avenue Suite 360 Wayne PA PENNSYLVANIA 19087 Executive Officer Jeffrey Martini 125 Strafford Avenue Suite 360 Wayne PA PENNSYLVANIA 19087 Executive Officer Biotechnology Decline to Disclose 06b false 2022-12-16 true true false 0 37704498 9704497 28000001 Total Remaining Amount to be sold is subject to potential additional investments, including the occurrence of Milestone Closing false 33 319634 true 0 Sales Commission payment deferred until occurrence of Milestone Closing 0 false Palvella Therapeutics, Inc. /s/Wesley H. Kaupinen Wesley H. Kaupinen President and CEO 2022-12-30